Glycemic status in diabetic and nondiabetic ESRD Patients with or without hemodialysis in rural hospital of Central Maharashtra.

ABSTRACT

Background: Diabetes is a potent cardiovascular risk factor in the general population as well as in people with end-stage renal disease (ESRD) undergoing maintenance dialysis treatment. Previous observational studies have yielded inconsistent results regarding the association between glycemic controls in patients receiving maintenance hemodialysis (MHD). Studies provide evidence that very poor glycemic control is associated with higher mortality in dialysis patients. The significance of the levels of glycosylated haemoglobin in non-diabetic patients with renal disease receiving maintenance hemodialysis remains unclear at the present time. The knowledge of HbA1c in patients with renal diseases could be important in assessing the overall prognosis in such patients and it also has implications in the assessment of their glycaemic status and in preventing post-dialysis morbidity and mortality. Aims & Objective: (1) To study the role of HbA1c as a marker of glycemic status in patients of kidney disease with or without MHD. (2) To compare the utility of fasting glucose level and HbA1c in accessing glycemic status and their relationship. Material and Methods: Study was conducted in the AVBRH, Jawaharlal Nehru medical college, Sawangi (M) Wardha by department of Biochemistry in collaboration with Department of Medicine. 30 patients undergoing maintenance hemodialysis and 30 patients of kidney diseases who are not undergoing MHD, has been taken from ABVRH Sawngi (Meghe). 30 age and sex matched healthy controls were also included in the study. 5.0 ml of blood has been collected from each subject after informed consent .Different parameters such as HbA1c, Fasting and random blood glucose, Urea creatinine, sodium potassium were evaluated in all the groups. Results: Study concluded that the HbA1c values in CKD patients undergoing hemodialysis is found above the normal range (6.71 ± 0.99) as compared to the control group (4.38 ± 0.52) while the results of HbA1c in CKD patients not going through hemodialysis found to be within the normal range (4.93 ± 0.52) and less than the patients going through the hemodialysis (6.71 ± 0.99) but more than the control group (4.38 ± 0.52). Conclusion: In non-diabetic patients with ESRD undergoing hemodialysis HbA1c may be used as a marker of impaired glucose metabolism and glycemic control is necessary to prevent future complications in these patients. Secondly in CKD patients not undergoing hemodialysis HbA1c value are more than control though they are under normal limit but it should be strictly monitored.